MAPT and Alzheimer disease: Total tau has previously been shown to be a marker progression from MCI to AD (Diniz et al., 2008) and associated with neurodegeneration regardless of the underlying condition (Jack and Holtzman, 2013) and may therefore be related to gamma/theta CFC.